2/10
08:30 am
tem
Tempus to Report Fourth Quarter and Full Year 2025 Financial Results on February 24
Neutral
Report
Tempus to Report Fourth Quarter and Full Year 2025 Financial Results on February 24
2/4
10:36 pm
tem
Tempus AI, Inc. (TEM): A Bull Case Theory [Yahoo! Finance]
Low
Report
Tempus AI, Inc. (TEM): A Bull Case Theory [Yahoo! Finance]
2/4
07:00 am
tem
Ambry’s Contributions to MAVEs Support Thousands of Patient Reclassifications and Expand to New Genes
Medium
Report
Ambry’s Contributions to MAVEs Support Thousands of Patient Reclassifications and Expand to New Genes
2/2
07:13 am
tem
Ambry Genetics Announces One Millionth Test Leveraging RNA to Improve Diagnostic Accuracy and Yield [Yahoo! Finance]
Low
Report
Ambry Genetics Announces One Millionth Test Leveraging RNA to Improve Diagnostic Accuracy and Yield [Yahoo! Finance]
2/2
07:00 am
tem
Ambry Genetics Announces One Millionth Test Leveraging RNA to Improve Diagnostic Accuracy and Yield
Low
Report
Ambry Genetics Announces One Millionth Test Leveraging RNA to Improve Diagnostic Accuracy and Yield
2/1
07:03 pm
tem
Tempus AI, Inc. (TEM) Strengthens Precision Medicine with New Tools, Partnerships, and Growth Milestones [Yahoo! Finance]
Low
Report
Tempus AI, Inc. (TEM) Strengthens Precision Medicine with New Tools, Partnerships, and Growth Milestones [Yahoo! Finance]
1/27
08:30 am
tem
Tempus Reveals Its AI-Driven IPS Test More Accurately Predicts Immunotherapy Benefit Compared to Conventional Biomarkers
Low
Report
Tempus Reveals Its AI-Driven IPS Test More Accurately Predicts Immunotherapy Benefit Compared to Conventional Biomarkers
1/24
05:10 am
tem
Tempus AI (NASDAQ:TEM) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Tempus AI (NASDAQ:TEM) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
1/23
09:48 am
tem
Tempus AI: Staying Bullish On Leading Healthcare AI Play [Seeking Alpha]
Low
Report
Tempus AI: Staying Bullish On Leading Healthcare AI Play [Seeking Alpha]
1/22
08:02 am
tem
Tempus AI Highlights Strong Growth At The J.P. Morgan Healthcare Conference [Seeking Alpha]
Low
Report
Tempus AI Highlights Strong Growth At The J.P. Morgan Healthcare Conference [Seeking Alpha]
1/21
08:30 am
tem
Tempus Announces the Launch of Paige Predict
Low
Report
Tempus Announces the Launch of Paige Predict
1/13
08:01 am
tem
Tempus AI (TEM) Soars 15% on $1.1-Billion Deal [Yahoo! Finance]
Medium
Report
Tempus AI (TEM) Soars 15% on $1.1-Billion Deal [Yahoo! Finance]
1/12
08:30 am
tem
Tempus and NYU Langone Health Announce Strategic Collaboration to Advance Precision Oncology
Medium
Report
Tempus and NYU Langone Health Announce Strategic Collaboration to Advance Precision Oncology
1/12
07:00 am
tem
Northwestern Medicine Selects Tempus to Expand Genomic Testing
Medium
Report
Northwestern Medicine Selects Tempus to Expand Genomic Testing
1/11
05:37 pm
tem
Tempus Achieves Record Total Contract Value Exceeding $1.1 Billion [Yahoo! Finance]
Medium
Report
Tempus Achieves Record Total Contract Value Exceeding $1.1 Billion [Yahoo! Finance]
1/11
05:30 pm
tem
Tempus Achieves Record Total Contract Value Exceeding $1.1 Billion
Medium
Report
Tempus Achieves Record Total Contract Value Exceeding $1.1 Billion
1/11
05:00 pm
tem
Tempus Announces Preliminary Fourth Quarter and Full Year 2025 Results
Medium
Report
Tempus Announces Preliminary Fourth Quarter and Full Year 2025 Results
1/8
08:30 am
tem
Tempus Announces Eight Abstracts Accepted for Presentation at the 2026 ASCO® Gastrointestinal Cancers Symposium
Low
Report
Tempus Announces Eight Abstracts Accepted for Presentation at the 2026 ASCO® Gastrointestinal Cancers Symposium
1/6
08:30 am
tem
Tempus to Present at 44th Annual J.P. Morgan Healthcare Conference
Medium
Report
Tempus to Present at 44th Annual J.P. Morgan Healthcare Conference
1/2
09:22 am
tem
TD Cowen Reaffirms Hold Rating on Tempus AI (TEM), Cites the Company's Position to be a Leader [Yahoo! Finance]
Medium
Report
TD Cowen Reaffirms Hold Rating on Tempus AI (TEM), Cites the Company's Position to be a Leader [Yahoo! Finance]
1/1
07:22 am
tem
Canaccord Lowers Price Objective On Tempus AI, Inc. (TEM) [Yahoo! Finance]
Medium
Report
Canaccord Lowers Price Objective On Tempus AI, Inc. (TEM) [Yahoo! Finance]
12/22
10:37 pm
tem
BofA and JPMorgan Lower Tempus AI, Inc. (TEM) Price Targets on Valuation Concerns [Yahoo! Finance]
Low
Report
BofA and JPMorgan Lower Tempus AI, Inc. (TEM) Price Targets on Valuation Concerns [Yahoo! Finance]
12/22
08:02 am
tem
Tempus AI (NASDAQ:TEM) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $95.00 to $80.00. They now have a "buy" rating on the stock.
Low
Report
Tempus AI (NASDAQ:TEM) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $95.00 to $80.00. They now have a "buy" rating on the stock.
12/16
07:06 pm
tem
Tempus AI Revenue Jumps 85% as Pricing Catalysts Line Up [Yahoo! Finance]
Medium
Report
Tempus AI Revenue Jumps 85% as Pricing Catalysts Line Up [Yahoo! Finance]
12/15
02:24 pm
tem
Tempus AI (NASDAQ:TEM) had its price target lowered by analysts at JPMorgan Chase & Co. from $85.00 to $80.00. They now have a "neutral" rating on the stock.
Low
Report
Tempus AI (NASDAQ:TEM) had its price target lowered by analysts at JPMorgan Chase & Co. from $85.00 to $80.00. They now have a "neutral" rating on the stock.